I’ve met Jesus during June 2023. Jesus works at Bayer Pharmaceuticals currently as the Head of Business Disruption. Love Stranger Things, AcceleRed, TeamRed, Science4Berlin, STEM4Health, Hackathons, Biotech, Digital Health, Startups, Web3, Networking For Health, Science, Technology, Pharma, Exobiology, Space, Science Fiction, Germany, Cuba, you can connect with Jesus in LinkedIn: https://www.linkedin.com/in/yeysus/ Twitter: https://twitter.com/yeysus Web3: yeysus.eth/.tez/.near POAPs collections in Welook.io: Bayer: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/1 Bayer Haemophilia: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/24 Bayer R&D DS&AI: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/25 Bayer R&D DS&AI Posters Madrid: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/26 Bayer Hellas / Greece: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/27 Bayer Product Supply: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/28 Bayer Berlin: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/29 Bayer IT: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/30 Bayer R&D: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/31 Bayer Communities: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/32 Bayer Medical Affairs: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/33

With the aim of protecting more and more Greek patients, a new product in Cardiovascular Medicine is launched. KERENDIA is now available for patients with CKD & Type 2 Diabetes. Welcome to Bayer Hellas internal Kerendia launch event, focusing on educating & preparing the Sales Team for a successful product promotion in the Greek market. In this event, you familiarized yourselves with the promotional materials & the role plays. This is the first POAP related to a pharmaceutical product. If you received this POAP, you are a True Pioneer in the Web3 space. Bayer is proudly promoting innovative practices. https://www.bayer.com/en/poap-tc

I am a pharmacist from Rio de Janeiro-Brazil and I work as a computational chemist at Bayer since 2021 in the Computational Molecular Design department in Wuppertal. I work side by side with chemists on different projects using our digital tools to design small molecules that maybe one day will help patients! I am passionate about my work and I have the opportunity to also be part of the Steering Group for Transformation and Leadership in the Drug Discovery Science to help transforming the way we work and communicate.

Hubble is a pioneering data hub that continuously integrates and enriches terabytes of external scientific textual data to support insight generation along the R&D value chain. It opens opportunities for statistical analyses, large-scale text-mining and other data science methodologies to tease out important details and detect trends within e.g., patents, scientific literature, and grants. The Hubble platform is available Bayer-wide, and offers API access for data scientists. This allows large scale, programmatic analysis as well as integration into processes and platforms. Hubble is a cornerstone of our digital transformation journey within R&D. It serves many users, systems and processes with key data & analyses by answering ~2 million queries per week. We continue to extend the platform to best support insight generation and scientific decision making with a precision medicine focus. For more information contact: Astrid Rheinländer.

Scientific work in Pharma R&D requires a reliable high-quality body of data and knowledge. Bayer Pharma R&D has an extremely large amount of scientific data. The use of a Data Catalog significantly improves the findability of data and serves as a key pillar in the implementation of a comprehensive data strategy.